Longboard Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Longboard Pharmaceuticals

09/05/2022 22:03

* Longboard Pharmaceuticals Inc  LBPH.OQ  reported a
quarterly
adjusted loss of 56 cents​​ per share for the quarter ended in
March. The mean expectation of five analysts for the quarter was
for a loss of 55 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Longboard Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 56 cents​.
    * The mean earnings estimate of analysts had fallen by
about 12.8%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Longboard Pharmaceuticals Inc shares had fallen by 11.2%
this
quarter and lost 2.9% so far this year.
    * The company reported a quarterly loss of $9.6 million.
    * Wall Street's median 12-month price target for Longboard
Pharmaceuticals Inc is $23.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated May 9 at 09:03 p.m.  ​All
figures in US dollars unless otherwise stated